Clinical significance of serum-derived exosomal PD-L1 expression in patients with advanced pancreatic cancer.
Se Jun ParkJu Yeon ParkKabsoo ShinTae Ho HongMyung Ah LeeYounghoon KimIn-Ho KimPublished in: BMC cancer (2023)
The serum-derived exoPD-L1 levels were higher in metastatic pancreatic cancer than locally advanced disease. Collectively, higher serum exoPD-L1 levels in patients with advanced pancreatic cancer suggested worse survival outcomes and may have clinical implications.